Genomic Approaches to Outcome Prediction in Prostate CancerFEBBO, Phillip G.Cancer. 2009, Vol 115, Num 13, pp 3046-3057, issn 0008-543X, 12 p., SUPConference Paper

New insights into prostate cancer biologyBALAKUMARAN, Bala S; FEBBO, Phillip G.Hematology/oncology clinics of North America. 2006, Vol 20, Num 4, issn 0889-8588, vii, 773-796 [25 p.]Article

Stromally expressed c-Jun regulates proliferation of prostate epithelial cellsWENHUA LI; WU, Chin-Lee; FEBBO, Phillip G et al.The American journal of pathology. 2007, Vol 171, Num 4, pp 1189-1198, issn 0002-9440, 10 p.Article

Fatty acid synthase expression defines distinct molecular signatures in prostate cancerROSSI, Sabrina; GRANER, Edgard; FEBBO, Phillip et al.Molecular cancer research. 2003, Vol 1, Num 10, pp 707-715, issn 1541-7786, 9 p.Article

Genomic Strategy for Targeting Therapy in Castration-Resistant Prostate CancerMENDIRATTA, Prateek; MOSTAGHEL, Elahe; GUINNEY, Justin et al.Journal of clinical oncology. 2009, Vol 27, Num 12, pp 2022-2029, issn 0732-183X, 8 p.Article

Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumorsALVAREZ, James V; FEBBO, Phillip G; RAMASWAMY, Sridhar et al.Cancer research (Baltimore). 2005, Vol 65, Num 12, pp 5054-5062, issn 0008-5472, 9 p.Article

Use of expression analysis to predict outcome after radical prostatectomy. DiscussionFEBBO, Phillip G; SELLERS, William R; CARROLL, Peter R et al.The Journal of urology. 2003, Vol 170, Num 6, pp S11-S20, issn 0022-5347, 2Conference Paper

Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancerFEBBO, Phillip G; RICHIE, Jerome P; OH, William K et al.Clinical cancer research. 2005, Vol 11, Num 14, pp 5233-5240, issn 1078-0432, 8 p.Article

Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancersBERCHUCK, Andrew; IVERSEN, Edwin S; NEVINS, Joseph R et al.Clinical cancer research. 2005, Vol 11, Num 10, pp 3686-3696, issn 1078-0432, 11 p.Article

MYC Activity Mitigates Response to Rapamycin in Prostate Cancer through Eukaryotic Initiation Factor 4E―Binding Protein 1―Mediated Inhibition of AutophagyBALAKUMARAN, Bala S; PORRELLO, Alessandro; HSU, David S et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 19, pp 7803-7810, issn 0008-5472, 8 p.Article

Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene ExpressionANDERS, Carey K; HSU, David S; NEVINS, Joseph R et al.Journal of clinical oncology. 2008, Vol 26, Num 20, pp 3324-3330, issn 0732-183X, 7 p.Article

Utilization Trends at a Multidisciplinary Prostate Cancer Clinic: Initial 5-Year Experience From the Duke Prostate CenterBIEHN STEWART, Suzanne; BANEZ, Lionel L; FEBBO, Phillip G et al.The Journal of urology. 2012, Vol 187, Num 1, pp 103-108, issn 0022-5347, 6 p.Article

Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancerHSU, David S; BALAKUMARAN, Bala S; DRESSMAN, Holly K et al.Journal of clinical oncology. 2007, Vol 25, Num 28, pp 4350-4357, issn 0732-183X, 8 p.Article

A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy UndersamplingKLEIN, Eric A; COOPERBERG, Matthew R; CHERBAVAZ, Diana B et al.European urology. 2014, Vol 66, Num 3, pp 550-560, issn 0302-2838, 11 p.Article

Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumorsPARIS, Pamela L; ANDAYA, Armann; ALBERTSON, Donna G et al.Human molecular genetics (Print). 2004, Vol 13, Num 13, pp 1303-1313, issn 0964-6906, 11 p.Article